Glaxo licenses AIDS drug to Aspen
In a move likely to have a broad impact on pharmaceutical-industry economics in developing-world markets, pharmaceutical company GloxoSmithkline PLC says it will allow a generic-drug maker in South
In a move likely to have a broad impact on pharmaceutical-industry economics in developing-world markets, pharmaceutical company GloxoSmithkline PLC says it will allow a generic-drug maker in South